[#item_full_content] A Phase 2 randomized, double-blind, placebo-controlled trial suggests that a cannabinoid combination of THC and CBD can rapidly and substantially reduce agitation in hospice-eligible people with dementia. The topline results come from the LiBBY (Life’s End Benefits of c Read More